BeiGene Ltd (NASDAQ:BGNE)

169.23
Delayed Data
As of Jul 20
 +5.12 / +3.12%
Today’s Change
65.58
Today|||52-Week Range
220.10
+73.18%
Year-to-Date
No recent news for BeiGene Ltd.

Today’s Trading

Previous close164.11
Today’s open165.12
Day’s range164.29 - 172.92
Volume279,252
Average volume (3 months)355,526
Market cap$9.1B
Data as of 4:00pm ET, 07/20/2018

Growth & Valuation

Earnings growth (last year)+43.03%
Earnings growth (this year)-233.28%
Earnings growth (next 5 years)--
Revenue growth (last year)+22,299.66%
P/E ratioNM
Price/Sales17.07
Price/Book11.51

Competitors

 Today’s
change
Today’s
% change
TYMETyme Technologies In...-0.07-2.35%
OASMOasmia Pharmaceutica...-0.13-8.26%
TEVATeva Pharmaceutical-0.13-0.56%
Data as of 4:00pm ET, 07/20/2018

Financials

Next reporting dateAugust 9, 2018
EPS forecast (this quarter)-$2.02
Annual revenue (last year)$239.2M
Annual profit (last year)-$93.4M
Net profit margin-39.06%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
John V. Oyler
President
Xiao Bin Wu
Corporate headquarters
Beijing, Beijing

Forecasts